FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals CLONAZEPAM ORALLY DISINTERGRATING Tablets Recall

CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0

Teva Pharmaceuticals USA, Inc. · Sellersville, PA

Risk level
Class II
Reported by FDA
Apr 10, 2013
Recall ID
D-237-2013
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled CLONAZEPAM ORALLY DISINTERGRATING Tablets starting Feb 7, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-237-2013 on Apr 10, 2013. Reason: Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity. Status: Terminated.

Why it was recalled

Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.

Product description

CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96

Lot numbers, UPCs & expiration codes

Lot # 32900136A, Exp. 05/14

Where it was sold

NC

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-237-2013
Classification
Class II
Status
Terminated
Recall initiated
Feb 7, 2013
FDA report date
Apr 10, 2013
Quantity
3 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc.

Original FDA data

Every field from FDA enforcement report D-237-2013, exactly as published.

Show all FDA fields
City
Sellersville
State
PA
Status
Terminated
Country
United States
Event ID
64305
Address
650 Cathill Rd
Code information
Lot # 32900136A, Exp. 05/14
Postal code
18960-1512
Report date
Apr 10, 2013
Product type
Drugs
Recall number
D-237-2013
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA, Inc.
Product quantity
3 boxes
Termination date
Jan 15, 2014
Reason for recall
Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP, 0.5 mg, 60 tablets (10 blister cards of 6 tablets each), TEVA PHARMACEUTICALS USA, Sellersville PA 18960, NDC #0555-0096-96
Distribution pattern
NC
Recall initiation date
Feb 7, 2013
Initial firm notification
Letter
Center classification date
Apr 1, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-237-2013, published Apr 10, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls